Difference between revisions of "MOC31"
Jump to navigation
Jump to search
| Line 11: | Line 11: | ||
*[[Liver metastases]].<ref name=pmid10937059/> | *[[Liver metastases]].<ref name=pmid10937059/> | ||
*[[Lung adenocarcinoma]].<ref name=pmid9490276>{{Cite journal | last1 = Ordóñez | first1 = NG. | title = Value of the MOC-31 monoclonal antibody in differentiating epithelial pleural mesothelioma from lung adenocarcinoma. | journal = Hum Pathol | volume = 29 | issue = 2 | pages = 166-9 | month = Feb | year = 1998 | doi = | PMID = 9490276 }}</ref> | *[[Lung adenocarcinoma]].<ref name=pmid9490276>{{Cite journal | last1 = Ordóñez | first1 = NG. | title = Value of the MOC-31 monoclonal antibody in differentiating epithelial pleural mesothelioma from lung adenocarcinoma. | journal = Hum Pathol | volume = 29 | issue = 2 | pages = 166-9 | month = Feb | year = 1998 | doi = | PMID = 9490276 }}</ref> | ||
*[[Invasive ductal carcinoma of the breast]].<ref name=pmid19391212>{{Cite journal | last1 = Pai | first1 = RK. | last2 = West | first2 = RB. | title = MOC-31 exhibits superior reactivity compared with Ber-EP4 in invasive lobular and ductal carcinoma of the breast: a tissue microarray study. | journal = Appl Immunohistochem Mol Morphol | volume = 17 | issue = 3 | pages = 202-6 | month = May | year = 2009 | doi = | PMID = 19391212 }}</ref> | |||
*[[Invasive lobular carcinoma]].<ref name=pmid19391212/> | |||
==See also== | ==See also== | ||
Revision as of 17:04, 4 February 2015
MOC31 is an immunostain.
It is useful for differentiating hepatocellular carcinoma from cholangiocarcinoma and liver metastases.[1]
Negative
- Hepatocellular carcinoma.[1]
- Malignant epithelioid mesothelioma - usually negative.[2]
Positive
- Cholangiocarcinoma.[1]
- Liver metastases.[1]
- Lung adenocarcinoma.[2]
- Invasive ductal carcinoma of the breast.[3]
- Invasive lobular carcinoma.[3]
See also
References
- ↑ 1.0 1.1 1.2 1.3 Proca, DM.; Niemann, TH.; Porcell, AI.; DeYoung, BR. (Jun 2000). "MOC31 immunoreactivity in primary and metastatic carcinoma of the liver. Report of findings and review of other utilized markers.". Appl Immunohistochem Mol Morphol 8 (2): 120-5. PMID 10937059.
- ↑ 2.0 2.1 Ordóñez, NG. (Feb 1998). "Value of the MOC-31 monoclonal antibody in differentiating epithelial pleural mesothelioma from lung adenocarcinoma.". Hum Pathol 29 (2): 166-9. PMID 9490276.
- ↑ 3.0 3.1 Pai, RK.; West, RB. (May 2009). "MOC-31 exhibits superior reactivity compared with Ber-EP4 in invasive lobular and ductal carcinoma of the breast: a tissue microarray study.". Appl Immunohistochem Mol Morphol 17 (3): 202-6. PMID 19391212.